je.st
news
BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430...
2014-12-15 18:43:01| Biotech - Topix.net
BioCryst Pharmaceuticals, Inc. today announced the dosing of the first subject in a randomized, placebo-controlled Phase 1 clinical trial to evaluate intramuscular administration of BCX4430 in healthy volunteers. BCX4430 is being developed as a potential treatment for hemorrhagic fever viruses, including Ebola virus and Marburg virus disease.
Tags: of
trial
phase
clinical
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||